ClariVest Asset Management’s Allogene Therapeutics ALLO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-16,430
| Closed | -$423K | – | 749 |
|
|
2021
Q3 | $423K | Sell |
16,430
-678
| -4% | -$17.5K | 0.01% | 451 |
|
|
2021
Q2 | $447K | Buy |
17,108
+6,784
| +66% | +$177K | 0.01% | 442 |
|
|
2021
Q1 | $364K | Buy |
10,324
+1,701
| +20% | +$60K | 0.01% | 451 |
|
|
2020
Q4 | $218K | Sell |
8,623
-11,732
| -58% | -$297K | 0.01% | 485 |
|
|
2020
Q3 | $768K | Sell |
20,355
-952
| -4% | -$35.9K | 0.03% | 321 |
|
|
2020
Q2 | $913K | Buy |
+21,307
| New | +$913K | 0.02% | 332 |
|